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Background: This proof-of-principle study demonstrates the usefulness and robustness of a novel array based
method for the elucidation of genetic causes underlying early pregnancy loss. A combined microarray utilizing
comparative genomic hybridization and single nucleotide polymorphism detection (CGH + SNP) was used for
parallel genome-wide identification of copy number and heterozygosity status of 70 products of conception. Results of
samples with previously determined aneuploidies were juxtaposed to those of a second cohort appearing normal after
routine genetic diagnostics.
Results: All chromosomal imbalances were confirmed, in one sample of the aneuploid panel additional monosomy X
was discovered. Genome-wide uniparental disomy causing a complete hydatidiform mole was identified in another
sample. No specimen featured microaberrations of obvious clinical relevance. Among cases with presumable euploidy,
one microdeletion and a single region of homozygosity were assigned unclear clinical significance.
Conclusions: The results prove the utility of combined imbalance and homozygosity mapping for routine workup of
these challenging specimens. Moreover parallel screening at submicroscopic resolution facilitates the detection of novel
genetic alterations underlying spontaneous abortion.
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Genetic diagnosticsBackground
About 8 to 20% of clinically confirmed pregnancies abort
spontaneously in the first trimester [1,2]. About half of
these early abortions can be explained by chromosome
aneuploidy. Non-genetic contributing factors include
immunological disorders, thyroid or blood coagulation
conditions, acute or chronic diseases of the mother,
stress or environmental influence. In order to determine
the best medical treatment for all possible causes under-
lying embryonic demise, genetic analyses of products
of conception (POCs) were introduced to diagnostic* Correspondence: Stefanie.Bug@synlab.com
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unless otherwise stated.routines decades ago. Since then, clinical geneticists have
been facing two major diagnostic concerns: First of all,
mosaic constellations in embryo or placenta remain a
profound analytical problem related to POC specimen
[3,4]. Mosaics can only be reliably assessed by compara-
tive analysis of different embryonic and/or chorionic cell
types, which is usually not feasible in a diagnostic setting
[5]. Moreover, there always is the suspicion of mutations
that lie beneath detection limits and resolution of rou-
tinely applied protocols. Studies conducted in this re-
spect aimed at the designation of clinically relevant
segmental imbalances (deletions or duplications) and uni-
parental disomy (UPD) [6-10]. Molecular karyotyping by
array based comparative genomic hybridization (aCGH) or
single nucleotide polymorphism (SNP) detection enabled. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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The results showed in unison that segmental chromosomal
aberrations seem non-recurrent and sporadic events in
spontaneous abortions.
Most often distal gains or losses arise from the pres-
ence of chromosome derivatives from a balanced trans-
location carrier parent. In this clinical context, the
introduction of precise imbalance mapping meant sig-
nificant progress. In other cases the pathogenic rele-
vance of microimbalances was sometimes hard to
evaluate at the state of knowledge on the human gen-
ome. The same applied to genomic segments displaying
UPD, which in general can be associated with genomic
imprinting disorders and autosomal recessive conditions
[20]. UPD often shows in mosaic constellations [21]. Po-
tentially, all these features could contribute to early fetal
loss. The occurrence of UPD increases with elevating an-
euploidy risks due to advancing maternal age [22]. Sys-
tematic studies concordantly reported low frequencies of
UPD in POCs, but discussed UPD as a possibly underes-
timated pathogenic factor for spontaneous abortion due
to detection limits of available methods [23-27]. UPD
comprises the concepts of uniparental heterodisomy
(UPHD) and isodisomy (UPID). However, the occur-
rence of either in POCs is unknown [28].
SNP profiling enables the identification of UPID via
homozygosity mapping. The analytical challenge lies in
the differentiation of pathogenic regions displaying ab-
sence of heterozygosity (AOH) from benign long con-
tiguous stretches of homozygosity occuring frequently in
the human genome [29,30].
The major advantage of array based cytogenomic ap-
proaches is that they overcome cell culture failure and-
most often- overgrowth by maternal cells [31]. Thus,
microarray screening has been repeatedly suggested as
first tier test in the analytical workup of missed abor-
tions [32-34].
Against this background, we customized a novel CGH +
SNP-8x60K microarray for POC analyses. A compari-
son of this approach to conventional platforms is givenTable 1 Juxtaposition of conventional CGH- and SNP-array te
Conventional aCGH Conventional SNP-array
Array design One target consists of one
60mer oligonucleotide
Allele-specific 60mer olionucl


















comparison with a diploid
reference sample
Determination of heterozygo
of A- and B-alleles and in silic
ence sample sets, deduction
from thatin Table 1. Representative hybridization profiles of the
novel platform are displayed in Figure 1. The com-
bined detection featured by CGH + SNP-arrays prom-
ised a superior robustness with regard to samples of
varying quality and thus a possible advantage for POC
analyses. With regard to this, the presented feasibility
study addressed two key questions: Firstly, if a com-
bined array approach at this resolution was optimal for
the reliable detection of known genomic aberrations
underlying first trimester fetal demise. Secondly, whether
this platform unmasked recurrent small copy number
associated or copy number neutral aberrations that could
be causative of pregnancy loss in specimens of normal
karyotype. To evaluate its utility in a diagnostic setting, the
novel test was applied to a representative probe panel from
routine diagnostics in our facility.
Results
High molecular weight genomic DNA was successfully
extracted from all 70 POC-samples. In 12 of them pro-
tein contamination could not be completely removed by
ethanol precipitation resulting in A260/280 < 1.8 (1.740-
1.795). Hybridization of respective DNA resulted in not-
ably noisier imbalance profiles (derivate log ratio spread
value (DLRS) = 0.16-0.29). However a lower DNA quality
was not associated with a general dropout of SNP data
(informative SNPs = 32.5-90.6%). Samples with A260/
280 > 1.8 and A260/230 > 2 displayed a DLRS <0.2 and
more than 80% informative SNPs. Although it was pos-
sible to reliably evaluate profiles of lower quality as well,
these parameters were determined as optimal for ana-
lyses on the novel array platform. The design comprised
a single region in 9q22.32, in which coincidental com-
bination of oligonucleotide CGH probes with suboptimal
hybridization properties lead to frequent false positive
indication of a 47 kb genomic loss.
Microarray data are available in the ArrayExpress data-
base (http://www.ebi.ac.uk/arrayexpress) under accession
number E-MTAB-1725. An overview is given in Table 2.
Array experiments confirmed all previously knownchniques to the combined approach chosen in this study
Novel CGH + SNP-array
eotide targets, arranged
e base each are
CGH + SNP-arrays contain both kinds of
probes
ber neutral Copy number and copy number neutral
deviations (LOH)
Comparative hybridization with a reference
sample
sity status by measuring
o comparison to refer-
of copy number status
Combined detection: Only one allele is
measured, the total number of alleles at given
loci are estimated from CGH-probe signals
Figure 1 Genome-wide CGH and SNP hybridization profiles for a sample displaying trisomy 4. Panel A: aCGH data, CN: copy number,
Panel B: SNP data, GT: genotype.
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in a specimen with 47,XX,+12 karyotype after routine
cytogenetics. It had displayed sparse proliferation in cul-
ture. Although a low log2-ratio of chromosome X in the
respective profile did not suggest it, array and karyotyp-
ing findings did not exclude the possible presence of a
placental mosaic. For two near-triploid specimen with
XXY-constellation, triploidy was indicated by low log2-
ratios of gonosomes in aCGH-profiles. Remarkably, in
one of them additional loss of chromosome 11 was
missed, whereas an additional gain of chromosome 21
in the other sample was called correctly. It was spe-
culated whether different aberration sizes or types of
imbalances mislead the algorithm to bivalent copy num-
ber determination. Tetraploidy in the two samples with
92,XXXX karyotype was missed.
In the panel of POCs with presumptive normal karyo-
type one aberration of obvious clinical significance was
unmasked: AOH affecting all chromosomes indicated
genome-wide UPID and thus the formation of a com-
plete hydatidiform mole in this patient. Interestingly, the
algorithm called only 2 heterozygous SNPs as inform-
ative (0.03%), which were in fact false calls for a dip-
loid genome build of two identical haploid paternal
chromosome sets.
The novel combined microarray did not discover any
alterations clearly associated with common microdeletion,−duplication or UPD-related syndromes. Separate from
whole chromosome aneuploidy, numbers of detected
microimbalances in aneuploid and euploid panels were
comparable and varied from 3 to 13 deviations per
sample (0.2 kb-4 Mb). Imbalances occurring frequently
in both groups overlapped with known polymorphic
chromosomal regions. Hybridizations of high quality
genomic DNA correlated with low numbers of de-
tected irregularities.
In one sample with normal karyotype a heterozygous
loss of 3 Mb was revealed targeting the chromosomal
region of 2p24.3. It comprised four genes (TRIB2,
FAM84A, NBAS (NAG) and DDX1), whose molecular
functions did not imply an obvious cellular cause for
miscarriage. However, potential pathogenicity was accre-
dited to the fact that the proximal breakpoint of the
deletion mapped close to MYCN. Its gene product, the
N-Myc protein, is a key regulator of skeleton morpho-
genesis and organogenesis during embryogenesis [36,37].
Breakpoint mapping by FISH with locus specific probes
failed due to insufficient cell integrity of the frozen
specimen. Thus, it could not be verified, whether the de-
letion affected regulatory elements of MYCN. Parental
samples were unavailable, so the loss was classified as
CNC (potentially pathogenic).
AOH counts per genome varied from 1 to 32. Inter-
vals ranged from 8.4 to 24.2 Mb in size. No POC
Table 2 Comparison of results obtained in the current study and results from diagnostic routine
POC Result after routine
diagnostics (obtained by
karyotyping, FISH or aCGH)b
Result obtained in











1 45,X arr (X)×1 Yes
2 45,X arr (X)×1 Yes
3 45,X arr (X)×1 Yes
4 45,X arr (X)×1 Yes
5 47,XX,+7 arr (7)×3 Yes
6 47,XX,+7 arr (7)×3 Yes
7 47,XX,+10 arr (10)×3 Yes
8 47,XX,+12 arr (10)×3 Yes
9 47,XX,+12 arr (12)×3,(X)×1 Yes, additionally monosomy X
detected
10 47,XX,+14 arr (14)×3 Yes
11 47,XX,+15 arr (15)×3 Yes
12 47,XX,+15 arr (15)×3 Yes
13 47,XX,+16 arr (16)×3 Yes
14 47,XY,+16 arr (16)×3 Yes
15 47,XY,+16 arr (16)×3 Yes
16 47,XX,+18 arr (18)×3 Yes
17 47,XY,+20 arr (20)×3 Yes
18 47,XY,+21 arr (21)×3 Yes
19 47,XX,+21 arr (21)×3 Yes
20 47,XX,+22 arr (22)×3 Yes
21 47,XX,+22 arr (22)×3 Yes
22 47,XY,+22 arr (22)×3 Yes
23 48,XX,+6,+10 arr (6)×3,(10)×3 Yes
24 48,XX,+7,+16 arr (7)×3,(16)×3 Yes
25 48,XY,+14,+20 arr (14)×3,(20)×3 Yes
26 48,XX,+18,+22 arr (18)×3,(22)×3 Yes
27 49,XX,+13,+16,+21 arr (13)×3,(16)×3,(21)×3 Yes
28 68,XXY,-11 arr (X)×1 ~ 2 No, gonosome profile indicates
polyploidy, but loss of chr. 11 was
missed
29 70,XXY,+21 arr (21)×3,(X)×1 ~ 2 Yes
30 92,XXXX arr (1–22,X)×2 No, tetraploidy was missed
31 92,XXXX arr (1–22,X)×2 No, tetraploidy was missed
Cell culture
failure
32 arr (4)×3c arr (4)×3 Yes
33 arr (15)×3c,d arr (15)×3 Yes
34 arr (16)×3c arr (16)×3 Yes









36 45,XY,rob (13;14) (q10;q10) arr (1–22)×2,(XY)×1 Yes
37 46,XX arr (1–22,X)×2 hmz Yes, additionally hydatidiform mole
detected
38 46,XY arr 2p24.3 (12,849,885-
15,823,789)×1
Yes, additionally CNC detected
Bug et al. Molecular Cytogenetics 2014, 7:43 Page 4 of 9
http://www.molecularcytogenetics.org/content/7/1/43
Table 2 Comparison of results obtained in the current study and results from diagnostic routine (Continued)
39 46,XX arr 6q23.2q24.31
(131,723,146-
147,738,560)×2 hmz
Yes, AOH of uncertain clinical
significance detected
40 46,XY arr 6q23.3q25.1
(135,836,902-
150,015,258)×2 hmz
Yes, but false positive AOH call
41 46,XY arr (1–22)×2,(XY)×1 Yes
42 46,XY arr (1–22)×2,(XY)×1 Yes
43 46,XY arr (1–22)×2,(XY)×1 Yes
44 46,XY arr (1–22)×2,(XY)×1 Yes
45 46,XY arr (1–22)×2,(XY)×1 Yes
46 46,XY arr (1–22)×2,(XY)×1 Yes
47 46,XY arr (1–22)×2,(XY)×1 Yes
48 46,XY arr (1–22)×2,(XY)×1 Yes
49 46,XY arr (1–22)×2,(XY)×1 Yes
50 46,XY arr (1–22)×2,(XY)×1 Yes
51 46,XX arr (1–22,X)×2 Yes
52 46,XX arr (1–22,X)×2 Yes
53 46,XX arr (1–22,X)×2 Yes
54 46,XX arr (1–22,X)×2 Yes
55 46,XX arr (1–22,X)×2 Yes
56 46,XX arr (1–22,X)×2 Yes
57 46,XX arr (1–22,X)×2 Yes
Cultured
villi
58 46,XX arr (1–22,X)×2 Yes
59 46,XX arr (1–22,X)×2 Yes
60 46,XX arr (1–22,X)×2 Yes
61 46,XX arr (1–22,X)×2 Yes
62 46,XX arr (1–22,X)×2 Yes
63 46,XX arr (1–22,X)×2 Yes













67 arr (1–22,X)×2e arr (1–22,X)×2 Yes
68 arr (1–22)×2,(XY)×1c arr (1–22)×2,(XY)×1 Yes
69 arr (1–22)×2,(XY)×1c arr (1–22)×2,(XY)×1 Yes
NFa 70 arr (1–22)×2,(XY)×1f arr (1–22)×2,(XY)×1 Yes
aNF: native fetal.
baccording to ISCN 2013 [35].
c4x180K (Agilent Technologies, Santa Clara, USA).
d8x60K (Agilent Technologies, Santa Clara, USA).
e24sure (BlueGnome, Ltd., Cambridge, UK).
f4x44K (Agilent Technologies, Santa Clara, USA).
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grade of parental consanguinity [38]. Segments with
AOH occurring in both panels were not assigned any
clinical relevance and evaluated as benign.In two euploid samples AOH mapped to 6q24, overlap-
ping with the UPD critical segment for transient neonatal
diabetes mellitus and at the same time with a reported re-
gion of biparental apparently benign homozygosity [39].
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14.2 Mb in 6q23.3q25.1. Follow-up by STR was possible in
the latter case. It revealed heterozygosity and thus, a tech-
nical artifact.
Discussion
The comprehensive analysis of POCs always represents
a challenge. It is usually met by a workflow of cyto-
genetic, molecular cytogenetic and molecular genetic
methods depending on their availability in the diagnostic
lab. This study demonstrates that the established micro-
array platform is suitable for the reliable simultaneous
detection of imbalances and AOH in abortion material.
It facilitates the unification of diagnostic steps in various
laboratory workflows, which helps to significantly reduce
costs.
Technical utility
A major advantage of molecular karyotyping is its inde-
pendency from proliferation of starting material in cell
culture. It also overcomes in vitro selection against cer-
tain aneuploidies, cultural artifacts or maternal cell over-
growth. Maternal contamination of the tissue used for
DNA extraction cannot always be precluded even after
meticulous preparation of chorionic villi. There are fur-
ther material-related aspects to consider in diagnostics,
especially with regard to mosaicism: While DNA is ex-
tracted from all cell types present in the villi sample,
karyotyping assesses mainly well-proliferating cells from
the extraembryonic mesoderm, and FISH cells of the
cytotrophoblast [5].
Good quality of genomic DNA reflected in excellent
DLRS-values for aCGH, but did not guarantee a high
percentage of informative SNP probes. We suspect post-
mortem DNA modification and/or degradation resulting
in incomplete or faulty restriction digestion not detect-
able by AGE. Alternative digestion assays with isoschizo-
mers lacking any methylation sensitivity did not alter
SNP profiles notably (data not shown).
Our observations suggest that SNP calls were more
readily affected by DNA quality than CGH calls. We
therefore evaluate the use of a combined CGH + SNP
approach superior to hybridizations to sole SNP arrays,
because copy numbers are “determined” via more robust
CGH, not by SNP based copy number “calling”.
SNP detection on the combined platform is substan-
tially different from that on sole SNP arrays. Instead of
direct measurement of both alleles at one locus, only
one allele is assessed by aCGH + SNP. Restriction diges-
tion is used to selectively remove one allele. Measure-
ment of the remaining non-digested allele and the copy
number state determined by aCGH are used to consti-
tute the presence of heterozygosity. This means the
combined chip does not have an equivalent statistic tothe B-allele frequency, which is the standard way in
which a triploid sample would be detected by a conven-
tional SNP array. Since aCGH is not able to detect poly-
ploidy, the linked SNP analysis proceeds assuming the
sample is diploid. Thus, the identification of triploid
samples in this study succeeded only for those, in which
the presence of a Y chromosome lead to low log2-ratios
of gonosomes. For the same reason, combined cytoge-
nomics did not overcome the inability of aCGH to dis-
tinguish samples of 46,XX karyotype from tetraploid
samples. Like conventional aCGH, the novel method
cannot detect ratio changes of sample to reference ex-
tending genome-wide.
The combination of aCGH and SNP approaches does
not fundamentally emend the detection of mosaicism
and chimerism. In contrast to sole SNP arrays, the
method is blind to mosaics of both UPHD and UPID
[40]. With regard to mosaic constellations of imbalances,
low log2-ratios indicating different genomes in the study
panel were due to known maternal contamination. Based
on our experience with medium resolution aCGH, most
often cytogenetically proven placental or fetal mosaics
display either as distinct gains or losses or not at all. In
routine diagnostics we report them only after verifica-
tion by karyotyping or FISH.
We point out that the specimen with the Robertsonian
translocation was assigned to the panel of normal samples.
Euploidy was confirmed by array analysis. Nevertheless we
emphasize in diagnostic reports that mosaicism of low level
trisomy cannot fully be excluded.
Diagnostic utility
We established a robust assay for the rapid detection of
aneuploidy and UPID in a one step analysis. Genome-
wide UPID is associated with complete hydatidiform
moles. Hydatidiform moles are at high risk of developing
into choriocarcinomas and demand specific medical
treatment.
Results of this pilot study show that the chosen probe
resolution is reasonable for oligonucleotide detection of
segmental aberrations in POCs, because it does not lead
to excessive calling of microalterations, which then have
to be evaluated with regard to their clinical significance.
At medium resolution, partial chromosome imbalances
due to derivative chromosomes from balanced reciprocal
translocation carrier parents will reliably be picked up
since those are usually detectable at the microscopic
level. Apart from this, microduplications and microdele-
tions unambiguously associated with early pregnancy
loss seem sporadic events. The clinical evaluation of
CNCs will become easier with the ongoing understand-
ing of functional elements in the human genome.
For the evaluation of partial AOH we consider it rea-
sonable to apply the UPD thresholds determined in
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in recombination, UPD usually affects stretches of
20 Mb or wider in interstitial and appr. 10 Mb in telo-
meric regions [39]. Segments of homozygosity smaller
than this are more likely to represent benign AOH. As
knowledge of epigenetic effects such as imprinting in-
creases, homozygosity mapping will become an import-
ant tool in the elucidation of pathogenetic mechanisms
in abortions. There is an urgent need for valid databases
on UPD effects on fetal demise. Now that it becomes
technically possible to generate these data, our platform
being a part thereof, they will hopefully arise. Strict dif-
ferentiation between UPHD and UPID in scientific and
medical reports will greatly promote this. Homozygosity
profiling as it is presented here, will only detect UPID.
For UPHD, both parents have to be included in the array
screening as well. In diagnostics this is very expensive,
but feasible (though not with current algorithm options
of this platform). However, at the current state of med-
ical science it is clear that segmental or complex UPD
arises only from co-occurrence of meiotic or mitotic
recombination, abnormal segregation, and subsequent
correction [41]. Therefore the risk of recurrence is negli-
gible versus the risk of invasive prenatal diagnosis in a
future pregnancy.
On the long road towards genetic analysis at base pair
resolution, we present a profound diagnostic method
that at the same time allows further insight into patho-
genic molecular mechanisms resulting in spontaneous
abortions. The clinical benefits of POC-analyses remain
unquestionable: they permit accurate genetic counseling
and the estimation of recurrence risks. Moreover they
help to determine the best medical treatment to fulfill
the couples’ desire for a healthy child.
Conclusion
We suggest genome-wide CGH + SNP profiling as a first
tier test for simultaneous detection of copy number as-
sociated and copy number neutral aberrations under-
lying spontaneous abortion. Although polyploidy and
structural rearrangements have to be assessed in further
diagnostic steps, the peculiar advantages of this novel
cytogenomic method are independency from cell culture
proliferation, reliable detection of chromosomal aneuploidy
and pathogenic microimbalances as well as genome-wide
UPID underlying hydatidiform moles.
Methods
This study was done on 70 samples of fetal tissue or
chorionic villi from early pregnancy losses remaining
after genetic diagnostics (native n =63, cultivated n =7).
Written informed consent was obtained from all patients
for the use of material from products of conception after
completion of genetic diagnostics and further use in thisstudy. Ethical approval was granted for this study by an
interdisciplinary institutional reviewer board of med-
ical and scientific experts of the participating centers.
From conventional cytogenetics, karyotypes were
known for 60 POCs. Due to cell culture failure, 10
samples were assessed by molecular cytogenetics: 2 of
them by fluorescent in situ hybridization (FISH) with
probes targeting chromosomes most commonly af-
fected by aneuploidies (13, 16, 18, 21, 22, X, Y) and 8
samples by genome-wide aCGH. If nondistinctive, fetal
origin of material had been verified by short tandem
repeat marker analysis (STR). Thus, the panel com-
prised 35 samples previously determined as aneuploid
(31 by karyotyping and 4 by aCGH) and 35 samples
that appeared euploid after diagnostic routine testing
(29 by karyotyping, 2 by FISH and 4 by aCGH, proto-
cols available upon request).
Specimens of dissected fetal tissue or cultured cells
were thawed and washed three times in phosphate buff-
ered saline (Invitrogen, Carlsbad, USA). Genomic DNA
was extracted utilizing the Maxwell®16 LEV Blood DNA
kit (Promega Corp., Madison, USA), MagNA Pure kit
(Roche, Grenzach-Wyhlen, Germany) or QIAamp DNA
Blood Mini kit (QIAGEN, Hilden, Germany) according
to respective manufacturers’ protocols. Concentration
and quality of genomic DNA was assessed spectrophoto-
metrically (NanoDrop® ND 1000, peqlab Biotechnologie
GmbH, Erlangen, Germany). If necessary, ethanol/sodium
acetate precipitation was performed. High molecular weight
of genomic DNA as well as complete restriction digestion
were verified by agarose gel electrophoresis (AGE) accord-
ing to standard laboratory protocols.
Sample-DNA was hybridized to custom CGH+ SNP-
8×60K microarrays (BlueGnome Ltd., Cambridge, UK).
The design was genome-wide, but targeted known disease
genes and regions (design identification: MUNCH005). It
was made up of 59 090 60mer oligonucleotides mapped to
the human genome according to the Genome Reference
Consortium Human Build 37 of February 2009 (GRCh37/
hg19). The practical resolution for aCGH was appr. 200 kb
corresponding to three consecutive deviating probes with
average spacing of 66 kb. The design comprised 18% SNP-
probes enabling the detection of stretches of homozygosity
of 13 Mb or wider. Respective male or female genomic
DNA of known haplotype derived from single individuals
displaying no clinical phenotype was used as reference
(SNPRef DNA, commercially not available, BlueGnome
Ltd.). Wherever applicable, samples were cohybridized with
sex-matched references according to the CytoChip Oligo
reference manual v 1.8 (BlueGnome Ltd.). Slides were
scanned in double pass mode at 3 μm resolution with a
G2565CA microarray scanner (Agilent Technologies, Santa
Clara, USA). Data were analyzed with software BlueFuse-
Multi versions 2.5 to 3.0 (BlueGnome Ltd.). In addition,
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ultaneously in a 3 Mb sliding window. Sex-mismatch de-
rived copy number deviations and benign AOH of
chromosome Y in male samples served as internal controls.
Detected imbalances were assigned either benign copy
number variation (CNV), pathogenic copy number alter-
ation (CNA) or copy number change of uncertain clinical
significance (CNC) [42]. Homozygous segments were rated
as benign, pathogenic, or AOH of uncertain clinical signifi-
cance. The following online databases were used in the
evaluation process: Database of Genomic Variants Beta
(DGVbeta, http://dgvbeta.tcag.ca/dgv/app/home), Decipher
(DECIPHER, http://decipher.sanger.ac.uk), International
Standards for Cytogenomic Arrays (ISCA, http://www.isca-
consortium.org) and the UPD-database of the University
Medical Centre of Jena, Germany (http://ssmc-tl.com/Start.
html).
For verification of homozygosity in the 6q24 chromo-
somal region, STR analyses were carried out utilizing the
PowerPlex® ES system (Promega Corp).
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